Publications by authors named "Niall Tebbutt"

Claim this Profile
C
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial.
Jeanne Tie, Yuxuan Wang, Jonathan M Loree, Joshua D Cohen, Rachel Wong, Niall C Tebbutt

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancers.
Masafumi Ikeda, Marcus-Alexander Wörns, Mehmet Akce, Chiun Hsu, Niall C Tebbutt

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fosl1 is a transcriptional effector of -driven intestinal tumorigenesis.
Zakia Alam, Rebecca Nightingale, Analia Lesmana, Cheng Liu, Laura J Jenkins, Niall C Tebbutt

iScience· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation grade is highly concordant between matched primary and metastatic colorectal cancer.
Camilla M Reehorst, Jennifer K Mooi, Charles J Uy, Kristen A Needham, Sarah Ellis, Niall C Tebbutt

Clin Exp Metastasis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant intraperitoneal chemotherapy in high-risk and cytology positive gastric cancer: a systematic review.
Brendan Desmond, Lobna Alukaidey, Zexi Allan, Carlos Cabalag, Nicholas J Clemons, Niall Tebbutt

Surg Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The current landscape of neoadjuvant therapy for resectable colon cancer.
Mei Chan, Tharani Krishnan, Amanda Townsend, Christos Karapetis, Amitesh Roy, Niall Tebbutt

Expert Rev Anticancer Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG).
Matthew E Burge, David Espinoza, Katrin Marie Sjoquist, Derrick Ho Siu, Rebecca Mercieca-Bebber, Niall C Tebbutt

Clin Colorectal Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database.
Jean-Baptiste Bachet, Aimery de Gramont, Morteza Raeisi, Manel Rakez, Richard M Goldberg, Niall C Tebbutt

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines.
Ian Y Luk, Jennifer K Mooi, Dmitri Mouradov, Tao Tan, Cameron M Scott, Niall C Tebbutt

Commun Biol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics evaluation of peritoneal fluid in gastroesophageal cancer (OMEGCA): protocol for a prospective multicentre cohort study to detect occult peritoneal metastases in patients undergoing curative-intent treatment.
David S Liu, Zexi Allan, Jeanne Tie, Katheryn Hall, Margaret M Lee, Niall C Tebbutt

PLoS One· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer.
Nick Pavlakis, Kohei Shitara, Katrin Sjoquist, Andrew Martin, Anthony Jaworski, Niall Tebbutt

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of locoregional therapy including liver transplantation in liver-only metastatic colorectal cancer: a review paper.
Laura Depauw, Amanda Townsend, Christos Karapetis, Amitesh Roy, Alan Wigg, Niall C Tebbutt

Expert Rev Anticancer Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell factor 1 (TCF-1) defines T cell differentiation in colorectal cancer.
Kelly Tran, Anita N Kumari, Dinesh Raghu, Daniel R A Cox, Su Kah Goh, Niall C Tebbutt

iScience· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17.
Arjun Gupta, Christopher J O'Callaghan, Liting Zhu, Derek J Jonker, Ralph P W Wong, Niall C Tebbutt

J Natl Cancer Inst· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.
Romain Cohen, Morteza Raeisi, Benoist Chibaudel, Qian Shi, Takayuki Yoshino, Niall C Tebbutt

Eur J Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study.
Susanna Hegewisch-Becker, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Niall C Tebbutt

J Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of radiotherapy in combination with systemic targeted therapies for treatment of hepatocellular carcinoma: a narrative review.
Madeleine L Hall, Sweet Ping Ng, Umbreen Hafeez, Niall Tebbutt, Marie Sinclair

Chin Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCL-X inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF colorectal cancer.
Laura J Jenkins, Ian Y Luk, Fiona Chionh, Tao Tan, Kristen Needham, Niall C Tebbutt

Cell Death Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritoneal Tumor DNA as a Prognostic Biomarker in Gastric Cancer: A Systematic Review and Meta-Analysis.
Zexi Allan, Sasha Witts, Darren J Wong, Margaret M Lee, Jeanne Tie, Niall C Tebbutt

JCO Precis Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancer.
Michael Jefford, Jon D Emery, Andrew James Martin, Richard De Abreu Lourenco, Karolina Lisy, Niall C Tebbutt

EClinicalMedicine· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer.
Tao Tan, Dmitri Mouradov, Margaret Lee, Grace Gard, Yumiko Hirokawa, Niall C Tebbutt

Cell Rep Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review.
Zexi Allan, Sasha Witts, Jeanne Tie, Niall Tebbutt, Nicholas J Clemons

Br J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database" Eur J Cancer. 2023 Jan;178:162-170.
Ofer Margalit, William S Harmsen, Einat Shacham-Shmueli, Molly M Voss, Ben Boursi, Niall C Tebbutt

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database.
Fang-Shu Ou, Daniel H Ahn, Jesse G Dixon, Axel Grothey, Yiyue Lou, Niall C Tebbutt

Cancers (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nurse-led emergency department avoidance model of care for patients receiving cancer therapy in the ambulatory setting: a health service improvement initiative.
Angela Mellerick, Georgina Akers, Niall Tebbutt, Tyler Lane, Rebecca Jarden

BMC Health Serv Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis